Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
19.81
+0.60 (3.14%)
Nov 5, 2024, 11:14 AM EST - Market open

Avanos Medical Statistics

Total Valuation

Avanos Medical has a market cap or net worth of $855.19 million. The enterprise value is $942.32 million.

Market Cap 855.19M
Enterprise Value 942.32M

Important Dates

The last earnings date was Wednesday, October 30, 2024, before market open.

Earnings Date Oct 30, 2024
Ex-Dividend Date n/a

Share Statistics

Avanos Medical has 43.16 million shares outstanding. The number of shares has decreased by -0.32% in one year.

Current Share Class 43.16M
Shares Outstanding 43.16M
Shares Change (YoY) -0.32%
Shares Change (QoQ) +0.65%
Owned by Insiders (%) 1.51%
Owned by Institutions (%) 91.93%
Float 39.31M

Valuation Ratios

The trailing PE ratio is 40.79 and the forward PE ratio is 12.29. Avanos Medical's PEG ratio is 0.59.

PE Ratio 40.79
Forward PE 12.29
PS Ratio 1.30
Forward PS 1.13
PB Ratio 0.72
P/FCF Ratio 22.65
PEG Ratio 0.59
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.22, with an EV/FCF ratio of 25.75.

EV / Earnings 60.02
EV / Sales 1.38
EV / EBITDA 9.22
EV / EBIT 16.74
EV / FCF 25.75

Financial Position

The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.16.

Current Ratio 2.22
Quick Ratio 1.04
Debt / Equity 0.16
Debt / EBITDA 1.73
Debt / FCF 5.52
Interest Coverage 4.43

Financial Efficiency

Return on equity (ROE) is 1.77% and return on invested capital (ROIC) is 2.38%.

Return on Equity (ROE) 1.77%
Return on Assets (ROA) 2.08%
Return on Capital (ROIC) 2.38%
Revenue Per Employee $180,721
Profits Per Employee $4,163
Employee Count 3,771
Asset Turnover 0.40
Inventory Turnover 1.90

Taxes

In the past 12 months, Avanos Medical has paid $4.40 million in taxes.

Income Tax 4.40M
Effective Tax Rate 16.86%

Stock Price Statistics

The stock price has decreased by -13.04% in the last 52 weeks. The beta is 0.93, so Avanos Medical's price volatility has been similar to the market average.

Beta (5Y) 0.93
52-Week Price Change -13.04%
50-Day Moving Average 23.03
200-Day Moving Average 20.85
Relative Strength Index (RSI) 27.74
Average Volume (20 Days) 208,753

Short Selling Information

The latest short interest is 754,811, so 1.75% of the outstanding shares have been sold short.

Short Interest 754,811
Short Previous Month 819,463
Short % of Shares Out 1.75%
Short % of Float 1.92%
Short Ratio (days to cover) 3.19

Income Statement

In the last 12 months, Avanos Medical had revenue of $681.50 million and earned $15.70 million in profits. Earnings per share was $0.34.

Revenue 681.50M
Gross Profit 378.30M
Operating Income 56.30M
Pretax Income 14.70M
Net Income 15.70M
EBITDA 102.20M
EBIT 56.30M
Earnings Per Share (EPS) $0.34
Full Income Statement

Balance Sheet

The company has $89.00 million in cash and $202.20 million in debt, giving a net cash position of -$113.20 million or -$2.62 per share.

Cash & Cash Equivalents 89.00M
Total Debt 202.20M
Net Cash -113.20M
Net Cash Per Share -$2.62
Equity (Book Value) 1.23B
Book Value Per Share 26.73
Working Capital 259.70M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $55.50 million and capital expenditures -$18.90 million, giving a free cash flow of $36.60 million.

Operating Cash Flow 55.50M
Capital Expenditures -18.90M
Free Cash Flow 36.60M
FCF Per Share $0.85
Full Cash Flow Statement

Margins

Gross margin is 55.51%, with operating and profit margins of 8.26% and 2.30%.

Gross Margin 55.51%
Operating Margin 8.26%
Pretax Margin 3.83%
Profit Margin 2.30%
EBITDA Margin 15.00%
EBIT Margin 8.26%
FCF Margin 6.13%

Dividends & Yields

Avanos Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.32%
Shareholder Yield 0.32%
Earnings Yield 1.89%
FCF Yield 4.41%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Hold
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Avanos Medical has an Altman Z-Score of 1.74 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.74
Piotroski F-Score 6